Key result
Subcutaneous furosemide demonstrated clinical utility for managing symptoms in 2 palliative care and hospice patients with congestive heart failure resistant to oral diuretics.
Why the study?
Does intermittent subcutaneous furosemide improve symptoms in palliative care and hospice patients with congestive heart failure resistant to oral diuretics?
Population
2 patients with congestive heart failure resistant to oral diuretics in an inpatient palliative care unit…
Design
Case_series
Authors
Loading...
May support symptom management in select palliative CHF cases; hypothesis-generating and should not yet change practice.
Case Report (n=2)
Does intermittent subcutaneous furosemide improve symptoms in palliative care and hospice patients with congestive heart failure resistant to oral diuretics?
Subcutaneous furosemide may be a viable alternative for managing volume overload symptoms in palliative care and hospice patients with CHF resistant to oral diuretics.
Farless et al. (2012) conducted a case report in Congestive heart failure (n=2). Subcutaneous furosemide was evaluated on Clinical utility for management of CHF symptoms. Subcutaneous furosemide demonstrated clinical utility for managing symptoms in 2 palliative care and hospice patients with congestive heart failure resistant to oral diuretics.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: